O Shaughnessy Asset Management LLC acquired a new stake in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 143,830 shares of the company's stock, valued at approximately $610,000. O Shaughnessy Asset Management LLC owned 0.14% of DocGo at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Centiva Capital LP purchased a new position in DocGo during the 3rd quarter valued at about $43,000. Prudential Financial Inc. purchased a new position in shares of DocGo during the fourth quarter valued at approximately $55,000. Royce & Associates LP bought a new stake in shares of DocGo in the 4th quarter worth approximately $64,000. Intech Investment Management LLC grew its stake in shares of DocGo by 76.7% in the 4th quarter. Intech Investment Management LLC now owns 32,834 shares of the company's stock worth $139,000 after buying an additional 14,247 shares during the last quarter. Finally, SG Americas Securities LLC increased its position in DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock valued at $183,000 after buying an additional 4,905 shares in the last quarter. Institutional investors own 56.44% of the company's stock.
DocGo Stock Down 3.3 %
DCGO traded down $0.08 during midday trading on Monday, hitting $2.31. 538,378 shares of the company traded hands, compared to its average volume of 749,464. The company's 50-day moving average is $3.53 and its 200 day moving average is $3.84. DocGo Inc. has a 52 week low of $2.29 and a 52 week high of $5.68. The firm has a market capitalization of $235.58 million, a PE ratio of 8.25, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the company. Stifel Nicolaus cut their target price on DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a "buy" rating to a "hold" rating and cut their price objective for the company from $5.00 to $2.85 in a research report on Friday, February 28th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $4.00 target price on shares of DocGo in a report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $4.89.
Check Out Our Latest Research Report on DocGo
DocGo Company Profile
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
